Okyanos Heart Institute Chief Medical Officer Co-Authors American College of Cardiology White Paper.
For more information about CV service lines and to download the white paper, visit http://bit.ly/NzznwT.
“Dr. Walpole has the necessary knowledge and experience to provide important information on the key components of a successful CV service line, a topic that is becoming increasingly relevant in cardiac care,” said Feshbach. “His participation in writing this white paper exemplifies both his commitment and Okyanos Heart Institute's commitment to staying up to date on emerging trends in cardiology to further our efforts in advancing the treatment options and the level of care available to patients.”
“Developing successful CV service lines is crucial to efficiently providing patients with the best care possible, and it is important that cardiologists have up-to-date information about this concept readily available to them,” said Walpole. “Cardiology is a field that is constantly changing and adapting to advances in medicine and the varying needs of patients. It is our duty as cardiologists to understand such changes and adaptations to best care for our patients.”
New Media Content:
Okyanos LinkedIn page:
Okyanos Facebook page:
Okyanos Twitter page:
About Okyanos Heart Institute:
Based in Freeport, the Bahamas, the Okyanos Heart Institute is a Center of Excellence (CoE) adhering to U.S. surgical center standards and led by Chief Medical Officer Howard T. Walpole Jr., M.D., MBA, FACC, FACAI, FSCAI, a leader of the American College of Cardiology for many years. The mission of Okyanos Heart Institute is to bring a new standard of care and a better quality of life to patients with chronic coronary artery disease using cardiac cell therapy. The Okyanos treatment utilizes cardiac cell therapy, a unique blend of stem and regenerative cells to support the growth of new blood vessels and to assist the heart in repairing tissue damaged by heart attack and disease. The Greek god of rivers, “Okyanos” symbolizes the primary mechanism of action that these adult stem cells have on ischemic (lack of blood flow) heart tissue, the result of the plaque deposits in the coronary arteries. The stem cells, derived from a person's adipose (fat) tissue, create new blood vessels, a process known as angiogenesis. These cells facilitate blood flow in the heart and intake and use of oxygen, as measured by a rigorous clinical trial known as the PRECISE trial, as well as cardiac cell therapy trials at leading research institutions. For more information, visit http://www.okyanos.com/.
MMI Public Relations
Okyanos Heart Institute
Contact via Email
|Printer friendly Cite/link Email Feedback|
|Publication:||PR.com (Press Releases)|
|Date:||Sep 29, 2012|
|Previous Article:||Unveiling in Sao Paulo of Public Art by Nicole Mouracade on Show Until December.|
|Next Article:||FXstreet.com News Available on MetaTrader Platforms.|